Skip to main content

MoneyWorks4Me

Johnson Pharmacare - Quaterly Results

01 Nov 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended September 2023. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended September 2023 is Rs. -0.02 millions as compared to Net Loss of Rs. -0.44 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 improved to -0.02% as compared to -0.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 25.27 -100.00 25.27 32.63 -22.56
Other Income 0.00 0.38 0.00 0.00 0.38 0.00 -15.14 0.00 0.00
PBIDT -0.02 -0.44 -95.45 -1.90 3.53 -153.82 -12.91 1.35 -1056.30
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.02 -0.44 -95.45 -1.90 3.53 -153.82 -12.91 1.35 -1056.30
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.02 -0.44 -95.45 -1.90 3.53 -153.82 -12.91 1.35 -1056.30
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.38 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.02 -0.44 -95.45 -1.90 3.53 -153.82 -12.91 0.97 -1430.93
Equity 550.00 550.00 0.00 550.00 550.00 0.00 550.00 550.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 13.97 0.00 -51.09 4.14 -1334.82
Peers
Company Name CMP
Redington 346.00
Adani Enterprises 2720.00
Amrapali Industries 34.50
Maxgrow India 178.80
Rashi Peripheral 691.20
View more..